Mobile Health App to Mitigate the Metabolic Effects of Androgen Deprivation Therapy

Inclusion Criteria:

Phase 1

All recruited participants must have owned a smartphone for >1 year
English-speaking.
Patients with prostate cancer aged between 40-75 years will be considered.
No specific timeframe after prostate cancer diagnosis will be required for these patients.
No limitations regarding their disease characteristics will be imposed (e.g. metastatic disease).
Patients may or may not be currently receiving treatment Staff members will be recruited from
Dana-Farber Cancer Institute Department of Medical Oncology,
Brigham and Women's Hospital, Department of Surgery. Staff members aged between 40-75 years old will be considered. Phase 2
Men diagnosed with prostate cancer presenting to DF/BWHCC
About to initiate ADT for the first time will be considered.
Age range 40-75-years
The ability to walk 400 m
Medical clearance from their primary physician
English speaking
Cognitively alert
Literate
Ability to read or hear with or without contacts/glass and hearing aid
Ownership of a smartphone for >1yr

Exclusion Criteria:

Men who have been under a rigorous structured exercise regime, such as individuals who engage in more than 900 minutes of moderate physical activity per week in the last 6 months will not be considered
Post-ADT treatment
Planned systemic chemotherapy
Planned treatment with abiraterone or enzalutamide
Bone metastases
Acute illness
Any musculoskeletal, cardiovascular, or neurologic disorders that could inhibit or put them at risk from exercising
Subordinates to the PI